aristolochic acid i has been researched along with Carcinoma, Renal Cell in 6 studies
aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clear cell renal cell carcinoma (ccRCC) is a heterogeneous disease with features that vary by ethnicity." | 1.56 | Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. ( Bai, F; Dong, J; Dong, ZH; Ge, LY; George Rozen, S; Li, RY; Lu, M; Lu, Y; Luo, GD; Ma, LL; Ma, RZ; Song, YM; Wang, GL; Wang, SY; Wang, X; Wang, XM; Wu, D; Zhang, SD, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, XM | 1 |
| Lu, Y | 1 |
| Song, YM | 1 |
| Dong, J | 1 |
| Li, RY | 1 |
| Wang, GL | 1 |
| Wang, X | 1 |
| Zhang, SD | 1 |
| Dong, ZH | 1 |
| Lu, M | 1 |
| Wang, SY | 1 |
| Ge, LY | 1 |
| Luo, GD | 1 |
| Ma, RZ | 1 |
| George Rozen, S | 1 |
| Bai, F | 1 |
| Wu, D | 1 |
| Ma, LL | 1 |
| Jelaković, B | 1 |
| Castells, X | 1 |
| Tomić, K | 1 |
| Ardin, M | 1 |
| Karanović, S | 1 |
| Zavadil, J | 2 |
| Turesky, RJ | 3 |
| Yun, BH | 2 |
| Brennan, P | 1 |
| Mates, D | 1 |
| Jinga, V | 1 |
| Harnden, P | 1 |
| Banks, RE | 1 |
| Blanche, H | 1 |
| Bihoreau, MT | 1 |
| Chopard, P | 1 |
| Letourneau, L | 1 |
| Lathrop, GM | 1 |
| Scelo, G | 1 |
| Hoang, ML | 1 |
| Chen, CH | 2 |
| Chen, PC | 1 |
| Roberts, NJ | 1 |
| Dickman, KG | 2 |
| Pu, YS | 2 |
| Vogelstein, B | 1 |
| Papadopoulos, N | 1 |
| Grollman, AP | 2 |
| Kinzler, KW | 1 |
| Rosenquist, TA | 1 |
| Moriya, M | 1 |
| Sidorenko, VS | 1 |
| Edwards, KL | 1 |
| Gnatenko, DV | 1 |
| Wu, L | 1 |
| Wu, XR | 1 |
| Schetter, AJ | 1 |
| Harris, CC | 1 |
6 other studies available for aristolochic acid i and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Asian People; Carcinoma, Renal Cell; China; Coho | 2020 |
Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Topics: Adult; Aged; Aristolochic Acids; Balkan Nephropathy; Carcinogens; Carcinoma, Renal Cell; Exome; Fema | 2015 |
Aristolochic acid exposure in Romania and implications for renal cell carcinoma.
Topics: Aristolochic Acids; Carcinoma, Renal Cell; Deoxyadenosines; Humans; Kidney Neoplasms; Mutation; Roma | 2016 |
Aristolochic Acid in the Etiology of Renal Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinogens; Carcinoma, Renal Cell; Case-Control | 2016 |
Aristolochic acid-associated urothelial cancer in Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional C | 2012 |
Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome.
Topics: Aristolochic Acids; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drugs, Chinese Herbal; Fema | 2012 |